OnKure Therapeutics, Inc.(OKUR)

Biotechnology · Boulder, CO

$2.52-0.11 (-4.18%)

Delayed quote: Oct 6, 2026, 2:49 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T18:52:31.186Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:52:31.186Z.

Quote observation: 2026-10-06T18:49:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -61,343,000
Quote market capitalization: 102,050,676
Total debt · period ending 2026-06-30: 926,000
Cash · period ending 2026-06-30: 166,502,000

FMP input reference: 352cae2fe5eed9f02885becd1bbca6bb54c51239af0254a5780fc03f1b1dafbc

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OKUR EBITDA Yield Metrics

EBITDA YIELD

N/A

OKUR Competitors' EBITDA Yield

OKUR

OnKure Therapeutics, Inc.

Current

Market Cap

$102.05M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs OKUR

Market Cap

$102.64M

EBITDA Yield

3.83%

TTM Avg

2.60%

3Y Avg

2.68%

5Y Avg

2.72%

BDTX

Black Diamond Therapeutics, Inc.

vs OKUR

Market Cap

$102.86M

EBITDA Yield

N/A

TTM Avg

6.77%

3Y Avg

6.77%

5Y Avg

6.77%

PLYX

Polaryx Therapeutics, Inc. Common Stock

vs OKUR

Market Cap

$103.73M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANIX

Anixa Biosciences, Inc.

vs OKUR

Market Cap

$104.62M

EBITDA Yield

N/A

TTM Avg

3.06%

3Y Avg

3.06%

5Y Avg

3.06%

Definitive Healthcare Corp.

vs OKUR

Market Cap

$105.04M

EBITDA Yield

204.58%

TTM Avg

162.58%

3Y Avg

142.94%

5Y Avg

38.81%

PYPD

PolyPid Ltd.

vs OKUR

Market Cap

$98.70M

EBITDA Yield

N/A

TTM Avg

1.73%

3Y Avg

1.73%

5Y Avg

132.35%

CRBP

Corbus Pharmaceuticals Holdings, Inc.

vs OKUR

Market Cap

$106.72M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMUX

Immunic, Inc.

vs OKUR

Market Cap

$107.01M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs OKUR

Market Cap

$97.16M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
OnKure Therapeutics, Inc. (OKUR)	$102.05M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.64M	3.83%	2.60%	2.68%	2.72%
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$102.86M	N/A	6.77%	6.77%	6.77%
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$103.73M	N/A	N/A	N/A	N/A
Anixa Biosciences, Inc. (ANIX)vs ›	$104.62M	N/A	3.06%	3.06%	3.06%
Definitive Healthcare Corp. (DH)vs ›	$105.04M	204.58%	162.58%	142.94%	38.81%
PolyPid Ltd. (PYPD)vs ›	$98.70M	N/A	1.73%	1.73%	132.35%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs ›	$106.72M	N/A	N/A	N/A	N/A
Immunic, Inc. (IMUX)vs ›	$107.01M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$97.16M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

OKUR EBITDA Yield Metrics

OKUR Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics